Lieff Cabraser Civil Justice Blog
Sarah London Named Executive Committee Member of AAJ’s Section on Toxic, Environmental and Pharmaceutical Torts

Sarah London Named Executive Committee Member of AAJ’s Section on Toxic, Environmental and Pharmaceutical Torts

Lieff Cabraser partner Sarah R. London has been appointed as an Executive Committee Member of the American Association for Justice’s Section on Toxic, Environmental and Pharmaceutical Torts (STEP). Ms. London has been active in the AAJ on an ongoing basis, including in many litigation-specific groups.

As noted by the AAJ, “STEP focuses on the toxic effects of pharmaceuticals, medical devices, pesticides and herbicides, consumer products, industrial pollution, and other environmental poisons. STEP exchanges information on subjects as varied as Daubert challenges, federal preemption, practice nuts and bolts, and the use/abuse of class actions.”

About the American Association for Justice

The American Association for Justice provides trial attorneys with information, professional support and a nationwide network that enables them to most effectively and expertly represent clients. The mission of the American Association for Justice is to promote a fair and effective justice system—and to support the work of attorneys in their efforts to ensure that any person who is injured by the misconduct or negligence of others can obtain justice in America’s courtrooms, even when taking on the most powerful interests. Visit the AAJ online at justice.org.

About Sarah London

A partner in our San Francisco office, Ms. London is a determined, skilled, and experienced advocate for the injured, employees, and consumers. She is experienced in all aspects of trial work, from drafting and arguing motions in limine, opposing Daubert challenges to plaintiffs’ experts and deposing defendants’ experts, and serving as lead trial counsel to writing successful post-trial and appellate briefs. Ms. London’s case work involvement includes: Florida Tobacco litigation, Zofran Infant Injury lawsuits, Toyota Sudden Acceleration litigation, and the Norvir antitrust case.